Jochems, C., Hodge, J. W., Fantini, M., Tsang, K. Y., Vandeveer, A. J., Gulley, J. L., & Schlom, J. (2017). ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody. Int J Cancer.

Jochems, Caroline, James W. Hodge, Massimo Fantini, Kwong Y. Tsang, Amanda J. Vandeveer, James L. Gulley, و Jeffrey Schlom. "ADCC Employing an NK Cell Line (haNK) Expressing the High Affinity CD16 Allele With Avelumab, an Anti-PD-L1 Antibody." Int J Cancer 2017.

Jochems, Caroline, et al. "ADCC Employing an NK Cell Line (haNK) Expressing the High Affinity CD16 Allele With Avelumab, an Anti-PD-L1 Antibody." Int J Cancer 2017.